Comorbidities in patients with revision hip arthroplasty

Background. According to the existing concept of risk factors, the outcome of hip arthroplasty (HA) is affected not only by the quality of the prosthetic work, but also by the presence of one or more concomitant diseases. Purpose of the study - to perform a frequency analysis of co-morbidities in pa...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	V. M. Prokhorenko, M. Zh. Azizov, Kh. Kh. Shakirov
Formato:	article
Lenguaje:	RU
Publicado:	Scientific Сentre for Family Health and Human Reproduction Problems 2017
Materias:	revision hip replacement comorbidity Science Q
Acceso en línea:	https://doaj.org/article/aabfef467a5e4bb4848c6a84789383e0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:aabfef467a5e4bb4848c6a84789383e0
record_format	dspace
spelling	oai:doaj.org-article:aabfef467a5e4bb4848c6a84789383e02021-11-23T06:14:38ZComorbidities in patients with revision hip arthroplasty2541-94202587-959610.12737/article_59e85b6a9149f2.80265222https://doaj.org/article/aabfef467a5e4bb4848c6a84789383e02017-09-01T00:00:00Zhttps://www.actabiomedica.ru/jour/article/view/446https://doaj.org/toc/2541-9420https://doaj.org/toc/2587-9596Background. According to the existing concept of risk factors, the outcome of hip arthroplasty (HA) is affected not only by the quality of the prosthetic work, but also by the presence of one or more concomitant diseases. Purpose of the study - to perform a frequency analysis of co-morbidities in patients who underwent revidion HA, depending on the timing of its conduct. Materials and methods. On the basis of the endoprosthesis clinic at the Novosibirsk Research Institute of Traumatology and Orthopedics, a continuous sample of data was performed from medical records of patients (n = 667), who underwent revision HA in the period of 2013-2015. Primary HA was performed in various medical institutions in Russia and abroad in the period of 1992-2015. The cases of revision Ha were divided according to the terms of their implementation: postoperative (up to 2 months, n = 11), early remote (more than 2 months but less than 5years after HA, n = 371) and late remote (more than 5 years, n = 285). Variable coding and matrix creation, frequency analysis, average and relative risk (RR) calculation were performed. Results. The RR of postoperative and early revision intervention after HA is calculated depending on the presence of concomitant diseases. As a reference group, cases of late revision HA are taken. Calculation of the RR showed that the presence of concomitant diseases increases the risk of failure of the endoprosthesis in the postoperative period (in diabetes mellitus type 2 - 4.3 times, with excessive body weight and obesity - 2.0, with diseases of the nervous system - 3.9, liver - 2.8, veins of the lower extremities - in 2.9 and with chronic anemia - 3.7 times). The risk of undergoing revision HA in the early remote period is 1.7 times higher in the presence of concomitant malignant neoplasm than in the late remote period (p < 0.1). RR decreases with ischemic heart disease, chronic pyelonephritis, cholelithiasis and other pathology of the musculoskeletal system, i.e., revision interventions are performed in these patients much later. Conclusions. When analyzing the concomitant pathology, significant differences in the incidence of chronic diseases were found depending on the timing of the revision HA. Chronic diseases, which are risk factors for early failure of the endoprosthesis, have been identified. In cases when the risk of complications is high due to comorbidity it is more appropriate to refuse from the operation altogether.V. M. ProkhorenkoM. Zh. AzizovKh. Kh. ShakirovScientific Сentre for Family Health and Human Reproduction Problemsarticlerevision hip replacementcomorbidityScienceQRUActa Biomedica Scientifica, Vol 2, Iss 5(1), Pp 136-140 (2017)
institution	DOAJ
collection	DOAJ
language	RU
topic	revision hip replacement comorbidity Science Q
spellingShingle	revision hip replacement comorbidity Science Q V. M. Prokhorenko M. Zh. Azizov Kh. Kh. Shakirov Comorbidities in patients with revision hip arthroplasty
description	Background. According to the existing concept of risk factors, the outcome of hip arthroplasty (HA) is affected not only by the quality of the prosthetic work, but also by the presence of one or more concomitant diseases. Purpose of the study - to perform a frequency analysis of co-morbidities in patients who underwent revidion HA, depending on the timing of its conduct. Materials and methods. On the basis of the endoprosthesis clinic at the Novosibirsk Research Institute of Traumatology and Orthopedics, a continuous sample of data was performed from medical records of patients (n = 667), who underwent revision HA in the period of 2013-2015. Primary HA was performed in various medical institutions in Russia and abroad in the period of 1992-2015. The cases of revision Ha were divided according to the terms of their implementation: postoperative (up to 2 months, n = 11), early remote (more than 2 months but less than 5years after HA, n = 371) and late remote (more than 5 years, n = 285). Variable coding and matrix creation, frequency analysis, average and relative risk (RR) calculation were performed. Results. The RR of postoperative and early revision intervention after HA is calculated depending on the presence of concomitant diseases. As a reference group, cases of late revision HA are taken. Calculation of the RR showed that the presence of concomitant diseases increases the risk of failure of the endoprosthesis in the postoperative period (in diabetes mellitus type 2 - 4.3 times, with excessive body weight and obesity - 2.0, with diseases of the nervous system - 3.9, liver - 2.8, veins of the lower extremities - in 2.9 and with chronic anemia - 3.7 times). The risk of undergoing revision HA in the early remote period is 1.7 times higher in the presence of concomitant malignant neoplasm than in the late remote period (p < 0.1). RR decreases with ischemic heart disease, chronic pyelonephritis, cholelithiasis and other pathology of the musculoskeletal system, i.e., revision interventions are performed in these patients much later. Conclusions. When analyzing the concomitant pathology, significant differences in the incidence of chronic diseases were found depending on the timing of the revision HA. Chronic diseases, which are risk factors for early failure of the endoprosthesis, have been identified. In cases when the risk of complications is high due to comorbidity it is more appropriate to refuse from the operation altogether.
format	article
author	V. M. Prokhorenko M. Zh. Azizov Kh. Kh. Shakirov
author_facet	V. M. Prokhorenko M. Zh. Azizov Kh. Kh. Shakirov
author_sort	V. M. Prokhorenko
title	Comorbidities in patients with revision hip arthroplasty
title_short	Comorbidities in patients with revision hip arthroplasty
title_full	Comorbidities in patients with revision hip arthroplasty
title_fullStr	Comorbidities in patients with revision hip arthroplasty
title_full_unstemmed	Comorbidities in patients with revision hip arthroplasty
title_sort	comorbidities in patients with revision hip arthroplasty
publisher	Scientific Сentre for Family Health and Human Reproduction Problems
publishDate	2017
url	https://doaj.org/article/aabfef467a5e4bb4848c6a84789383e0
work_keys_str_mv	AT vmprokhorenko comorbiditiesinpatientswithrevisionhiparthroplasty AT mzhazizov comorbiditiesinpatientswithrevisionhiparthroplasty AT khkhshakirov comorbiditiesinpatientswithrevisionhiparthroplasty
_version_	1718417026146369536

Comorbidities in patients with revision hip arthroplasty

Ejemplares similares